BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38637263)

  • 21. Deciphering Serous Effusions Using the New International System for Reporting Serous Fluid Cytopathology.
    Mandava H; Venkata Renuka I; Potti R; Mounica B; Kalla I
    Cureus; 2024 May; 16(5):e60042. PubMed ID: 38774462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Stratification of Pleural Fluid Cytology Based on the International System for Reporting Serous Fluid Cytology in a Tertiary Care Centre.
    Bharti S; Nalwa A; Elhence PA; Rao M; Bharti JN; Khera S; Vedant D; Vishwajeet V; Goel A
    Acta Cytol; 2022; 66(5):449-456. PubMed ID: 35413720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment.
    Pergaris A; Stefanou D; Keramari P; Sousouris S; Kavantzas N; Gogas H; Mikou P
    Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal Volume Assessment for Serous Fluid Cytology.
    Christofidis K; Theochari M; Mavropoulos Papoudas S; Kiohou L; Sousouris S; Dimitriadou A; Volakakis N; Maounis N; Mikou P
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Novel Tiered Reporting System in Serous Fluid Cytology and Risk of Malignancy Assessment: A Retrospective Study in a Tertiary Care Center.
    Alashetty S; Sadasivan B; Dharmalingam P; Rajagopal N; Kavya L; Pai MM
    J Cytol; 2023; 40(3):107-113. PubMed ID: 37745807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Root cause analysis of indeterminate diagnoses in serous fluids cytopathology.
    Gokozan HN; Harbhajanka A; Lyden S; Michael CW
    Diagn Cytopathol; 2021 May; 49(5):633-639. PubMed ID: 33125186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The International System for Reporting Serous Fluid Cytopathology: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies.
    Jamal FE; Vey JA; Proctor T; Ishak A; Schmitt FC; Nikas IP
    Adv Anat Pathol; 2024 Jul; 31(4):256-264. PubMed ID: 38695284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the Milan System for Reporting Salivary Gland Cytopathology: A 5-year institutional experience.
    Viswanathan K; Sung S; Scognamiglio T; Yang GCH; Siddiqui MT; Rao RA
    Cancer Cytopathol; 2018 Aug; 126(8):541-551. PubMed ID: 29797690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of CD68 immunohistochemistry in categorizing benign nonmesothelial cell population and refining "atypical" category in serous fluid cytology.
    Savari O; Jassim S; Ferrer H; Ganocy SJ; Ganesan S
    Diagn Cytopathol; 2020 Dec; 48(12):1199-1204. PubMed ID: 32644272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The international system for reporting serous fluid cytopathology-diagnostic categories and clinical management.
    Pinto D; Chandra A; Crothers BA; Kurtycz DFI; Schmitt F
    J Am Soc Cytopathol; 2020; 9(6):469-477. PubMed ID: 32620534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of algorithmic cytomorphological assessment and immunocytochemistry with the international system for reporting serous fluid cytopathology on pericardial fluid cytology.
    Li JJX; Cheung W; Ng JKM; Tse GM
    J Clin Pathol; 2023 Aug; ():. PubMed ID: 37643837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The international system for serous fluid cytopathology: Interobserver agreement.
    Layfield LJ; Yang Z; Vazmitsel M; Zhang T; Esebua M; Schmidt R
    Diagn Cytopathol; 2022 Jan; 50(1):3-7. PubMed ID: 34784101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of cytology in distinguishing malignant mesothelioma: An institutional experience of 210 cases reclassified according to the International System for Reporting Serous Fluid Cytopathology (ISRSFC).
    Straccia P; Magnini D; Trisolini R; Lococo F; Chiappetta M; Cancellieri A
    Cytopathology; 2022 Jan; 33(1):77-83. PubMed ID: 34046958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of the Milan System for Reporting Submandibular Gland Cytopathology: An international, multi-institutional study.
    Maleki Z; Baloch Z; Lu R; Shafique K; Song SJ; Viswanathan K; Rao RA; Lefler H; Fatima A; Wiles A; Jo VY; Wang H; Fadda G; Powers CN; Ali SZ; Pantanowitz L; Siddiqui MT; Nayar R; Klijanienko J; Barkan GA; Krane JF; Rossi ED; Callegari F; Kholová I; Bongiovanni M; Faquin WC; Pusztaszeri MP
    Cancer Cytopathol; 2019 May; 127(5):306-315. PubMed ID: 31050186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of the international system for reporting serous fluid cytopathology on reporting various body fluids; experience of a tertiary care hospital.
    Kolte S; Zaheer S; Aden D; Ranga S
    Cytojournal; 2022; 19():52. PubMed ID: 36128470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RISK OF MALIGNANCY IN THYROID CYTOLOGY: THE IMPACT OF THE RECLASSIFICATION OF NONINVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES (NIFTP).
    Ventura M; Melo M; Fernandes G; Carrilho F
    Endocr Pract; 2019 Jul; 25(7):642-647. PubMed ID: 30865528
    [No Abstract]   [Full Text] [Related]  

  • 37. Malignancy risk and reproducibility associated with atypia of undetermined significance on thyroid cytology.
    Mathur A; Najafian A; Schneider EB; Zeiger MA; Olson MT
    Surgery; 2014 Dec; 156(6):1471-6; discussion1476. PubMed ID: 25218896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of the Milan System for Reporting Salivary Gland Cytology, with focus on the incidence and histologic correlates of atypia of undetermined significance (AUS) and salivary gland neoplasm of uncertain malignant potential (SUMP): A 3-year institutional experience.
    Cormier CM; Agarwal S
    Cancer Cytopathol; 2022 Apr; 130(4):303-312. PubMed ID: 34875145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serous fluid cytopathology: International system].
    Basset C; Collin L; Vielh P; Courtade-Saïdi M;
    Ann Pathol; 2023 Mar; 43(2):96-113. PubMed ID: 36907792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reassessing the optimal volume for malignancy detection in serous fluid cytology.
    Coconubo DM; Baskota SU; Li R; Srivastava P; Cuda J; Khader S
    Cancer Cytopathol; 2022 Jul; 130(7):551-557. PubMed ID: 35468659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.